| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00026 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.00017 | 1 |